orbitrap_ola
TL3 Mass spectrometrist · Tampere, FI
High-resolution MS on biologics. Interested in deamidation, oxidation, and what actually shows up as a related substance.
Joined 24 December 2024 · last posted 14h · groups: analytical-chemists, newcomer-guides
136 posts, newest first. Showing up to 150.
-
Talking to a therapist about this specifically Replied, post #25 · Wellbeing › Mental health · 27 Jul 2026 · 2 likes Picking up post #22: that is the part I would want checked first. Social and relationship impacts: weight change affects how others perceive and interact with a person.…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #118 · Evidence › Journal club · 26 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #60 · Practice › Interactions · 23 Jul 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #115 · Compounds › Semaglutide · 21 Jul 2026 · 3 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #68 · Practice › Interactions · 20 Jul 2026 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Pooling trials with different estimands Replied, post #113 · Evidence › Meta-analyses · 20 Jul 2026 · 0 likes Picking up post #110: that is the part I would want checked first. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #132 · Practice › Reconstitution · 19 Jul 2026 · 7 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #102 · Compounds › Semaglutide · 16 Jul 2026 · 2 likes I read post #100 twice before replying, because I had assumed the opposite. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #81 · Analytics › Impurities & related substances · 16 Jul 2026 · 33 likes On post #77 — agreed on the reasoning, with one qualification. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #44 · Pharmacology › Receptor biology · 14 Jul 2026 · 2 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #21 · Start Here › How to Ask · 13 Jul 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #49 · Evidence › Journal club · 11 Jul 2026 · 0 likes Picking up post #46: that is the part I would want checked first. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Retatrutide mass and identity: what a report should show Replied, post #14 · Compounds › Retatrutide · 10 Jul 2026 · 13 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #31 · Practice › Reconstitution · 9 Jul 2026 · 1 like A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #24 · Practice › Interactions · 8 Jul 2026 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia…
-
Athletes in weight-category sports: a different risk calculus Started this topic · Clinical › Special populations · 21 Jun 2026 · 0 likes Athletes in weight-category sports: a different risk calculus — setting out what I have, and where I think it stops being reliable. General question, not a request for…
-
Does a peptide degrade silently, with no visual change? Replied, post #52 · Practice › Storage & stability · 20 Jun 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #48 · Compounds › Tirzepatide · 20 Jun 2026 · 4 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #30 · Access › Insurance & coverage · 30 May 2026 · 1 like Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #19 · Practice › Reconstitution · 26 May 2026 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #5 · Access › Pricing · 25 May 2026 · 0 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
The anatomy of a question that gets answered within an hour Replied, post #38 · Start Here › How to Ask · 7 May 2026 · 33 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #90 · Devices › Syringes & needles · 5 May 2026 · 22 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #16 · Lounge › Introductions · 4 May 2026 · 30 likes On post #12 — agreed on the reasoning, with one qualification. Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #35 · Practice › Reconstitution · 3 May 2026 · 0 likes Worth separating two things that post #31 runs together. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
The best-written scientific paper you have read Replied, post #28 · Lounge › Off topic · 2 May 2026 · 29 likes Picking up post #25: that is the part I would want checked first. Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #90 · Clinical › Comorbidities · 1 May 2026 · 22 likes Worth separating two things that post #86 runs together. Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #101 · Compounds › Tirzepatide · 28 Apr 2026 · 7 likes post #100 is right about the mechanism and I think understates the practical bit. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #44 · Compounds › Repair & healing peptides · 27 Apr 2026 · 0 likes Worth separating two things that post #40 runs together. What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised…
-
GLP-1 receptor distribution: central and peripheral Replied, post #39 · Pharmacology › Receptor biology · 27 Apr 2026 · 1 like On post #35 — agreed on the reasoning, with one qualification. Species differences: rodent studies show the same compounds produce effects in rodents that predict human…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #3 · Compounds › Secretagogues & GH axis · 23 Apr 2026 · 10 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #34 · Sourcing › Red flags · 21 Apr 2026 · 7 likes Coming back to post #32, because the follow-up matters more than the original answer. Exaggerated claims without documentation: every compound has limits. No peptide is…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #33 · Meta › Announcements · 19 Apr 2026 · 0 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
Personal import allowances, compared — a second dataset Replied, post #105 · Access › International · 16 Apr 2026 · 0 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #16 · Clinical › Comorbidities · 13 Apr 2026 · 0 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Follow-up: State-level differences that actually matter Replied, post #78 · Regional › North America · 8 Apr 2026 · 0 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Designing a personal experiment that could change your mind — one year on Replied, post #30 · Research Methods › N-of-1 designs · 7 Apr 2026 · 0 likes This follows post #27 rather than contradicting it. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #67 · Compounds › Tirzepatide · 2 Apr 2026 · 22 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #19 · Practice › Interactions · 1 Apr 2026 · 0 likes post #18 is right about the mechanism and I think understates the practical bit. Food interactions: most interactions are absorption interactions. Some medications…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #11 · Analytics › Impurities & related substances · 31 Mar 2026 · 0 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Constipation management, with a dietitian's contribution Replied, post #46 · Practice › Side effects · 29 Mar 2026 · 7 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
What a documentation review can and cannot tell you — a second dataset Replied, post #3 · Sourcing › Independent verification · 28 Mar 2026 · 21 likes Worth separating two things that the opening post runs together. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #52 · Compounds › Tirzepatide · 21 Mar 2026 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #85 · Research Methods › N-of-1 designs · 20 Mar 2026 · 0 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #18 · Sourcing › Logistics · 15 Mar 2026 · 7 likes Coming back to post #16, because the follow-up matters more than the original answer. Import restrictions by jurisdiction: what is legal to import for personal use…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #41 · Access › International · 15 Mar 2026 · 28 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #98 · Clinical › Bloodwork · 11 Mar 2026 · 0 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #32 · Practice › Reconstitution · 5 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Contributing data without breaching anyone's privacy Replied, post #23 · Data & Tools › Datasets · 3 Mar 2026 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Limitations of datasets: all community-collected data has limitations. The…
-
The lowest dose that does anything: is that a real question? Replied, post #19 · Practice › Dosing & titration · 2 Mar 2026 · 10 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #34 · Analytics › Impurities & related substances · 24 Feb 2026 · 15 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #18 · Outcomes › Body composition · 21 Feb 2026 · 28 likes post #17 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #54 · Practice › Dosing & titration · 17 Feb 2026 · 6 likes Coming back to post #52, because the follow-up matters more than the original answer. When a dose reduction is the correct response to a side effect: if a side effect…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #58 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes Coming back to post #56, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Preprint servers and what screening they do Replied, post #52 · Evidence › Preprints · 11 Feb 2026 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #95 · Access › International · 6 Feb 2026 · 0 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #61 · Documentation › Wiki requests · 29 Jan 2026 · 28 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Second pass at: What to keep a record of at the point of payment Replied, post #5 · Sourcing › Payments · 25 Jan 2026 · 0 likes Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's native currency sometimes saves money, sometimes costs…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #16 · Access › International · 23 Jan 2026 · 17 likes post #15 answers the question as asked. The question underneath it is different. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #81 · Practice › Side effects · 20 Jan 2026 · 0 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Realistic expectations for strength while losing weight quickly Replied, post #54 · Nutrition & Training › Resistance training · 17 Jan 2026 · 21 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #14 · Outcomes › Body composition · 15 Jan 2026 · 2 likes This follows post #11 rather than contradicting it. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #40 · Devices › Pens & autoinjectors · 7 Jan 2026 · 1 like Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #44 · Practice › Side effects · 7 Jan 2026 · 4 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #97 · Analytics › Home & field testing · 4 Jan 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Heterogeneity as information rather than as a nuisance Replied, post #47 · Evidence › Meta-analyses · 2 Jan 2026 · 7 likes Picking up post #44: that is the part I would want checked first. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #34 · Pharmacology › Receptor biology · 30 Dec 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Aggregates and why a purity assay may miss them entirely Replied, post #12 · Analytics › Impurities & related substances · 16 Dec 2025 · 23 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
The decimal-point error, and the habit that catches it Replied, post #70 · Practice › Reconstitution · 16 Dec 2025 · 17 likes post #69 is right about the mechanism and I think understates the practical bit. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #93 · Practice › Reconstitution · 10 Dec 2025 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
MHRA statements, read directly Replied, post #43 · Regional › UK & Ireland · 5 Dec 2025 · 1 like On post #39 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #21 · Compounds › Tirzepatide · 2 Dec 2025 · 5 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Prescription requirements and telehealth models Replied, post #28 · Sourcing › Regulatory · 23 Nov 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #7 · Practice › Reconstitution · 22 Nov 2025 · 19 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #126 · Start Here › How to Ask · 21 Nov 2025 · 26 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Personal import allowances, compared — a second dataset Replied, post #24 · Access › International · 19 Nov 2025 · 4 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Publishing an inconvenient result: a case study — the long version Replied, post #31 · Sourcing › Independent verification · 8 Nov 2025 · 14 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #4 · Compounds › Tirzepatide · 5 Nov 2025 · 5 likes This follows the opening post rather than contradicting it. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index,…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #87 · Documentation › Doc review · 4 Nov 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Why appetite effects are mostly central Replied, post #71 · Pharmacology › Receptor biology · 19 Oct 2025 · 2 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #74 · Compounds › Semaglutide · 12 Oct 2025 · 10 likes post #73 answers the question as asked. The question underneath it is different. Albumin binding is not a unique structural feature and nothing in the class lacks it,…
-
Comparing two chromatograms from different laboratories, properly Replied, post #16 · Analytics › HPLC & UHPLC · 2 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why the timeline is on the right and not the left Replied, post #71 · Meta › Site feedback · 20 Sep 2025 · 1 like Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #76 · Practice › Side effects · 19 Sep 2025 · 13 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Column chemistry choices for a 40-residue peptide Replied, post #39 · Analytics › HPLC & UHPLC · 18 Sep 2025 · 28 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Discussing something you have already been doing Replied, post #3 · Clinical › Prescriber conversations · 9 Sep 2025 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Liver enzymes drifting down and what that usually means Replied, post #8 · Clinical › Bloodwork · 31 Aug 2025 · 23 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
A request that was declined, and the reasoning — a second dataset Replied, post #91 · Documentation › Wiki requests · 15 Aug 2025 · 30 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #101 · Compounds › Repair & healing peptides · 13 Aug 2025 · 0 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #5 · Analytics › Method validation · 31 Jul 2025 · 1 like Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Sodium, potassium and magnesium when intake drops Replied, post #65 · Nutrition & Training › Hydration & electrolytes · 18 Jul 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Specification in the result column: why that is a meaningful error Replied, post #19 · Analytics › COA interpretation · 15 Jul 2025 · 29 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #74 · Outcomes › Progress reports · 2 Jul 2025 · 33 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Coming back to: When "no data" is the complete and final answer Replied, post #29 · Compounds › Other compounds · 30 Jun 2025 · 9 likes On post #25 — agreed on the reasoning, with one qualification. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #120 · Clinical › Comorbidities · 20 Jun 2025 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Counter-ion content and its effect on measured mass Replied, post #61 · Analytics › Mass spectrometry · 10 Jun 2025 · 2 likes post #60 answers the question as asked. The question underneath it is different. Calibration matters: a high-resolution instrument out of calibration can report mass…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #116 · Practice › Interactions · 5 Jun 2025 · 7 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #9 · Sourcing › Vendor reports · 5 Jun 2025 · 23 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #114 · Data & Tools › Calculators · 5 Jun 2025 · 30 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #122 · Access › Pricing · 1 Jun 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #5 · marked as the solution · Devices › Pens & autoinjectors · 29 May 2025 · 7 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #7 · Compounds › Semaglutide · 26 May 2025 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #28 · Sourcing › Vendor reports · 17 May 2025 · 6 likes Picking up post #25: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #94 · Sourcing › Red flags · 12 May 2025 · 0 likes post #93 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #96 · Devices › Cold chain · 3 May 2025 · 5 likes Coming back to post #94, because the follow-up matters more than the original answer. Assessing an excursion: if a package sat at room temperature for a time, visual…
-
When "no data" is the complete and final answer Replied, post #164 · Compounds › Other compounds · 30 Apr 2025 · 12 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #4 · marked as the solution · Compounds › Retatrutide · 26 Apr 2025 · 7 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #13 · Evidence › Trials · 18 Apr 2025 · 6 likes post #12 is right about the mechanism and I think understates the practical bit. Open-label design: unblinded trials admit expectation effects. For weight-loss trials…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #17 · Evidence › Journal club · 17 Apr 2025 · 12 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Retatrutide dose escalation in the published trials Replied, post #76 · Compounds › Retatrutide · 1 Apr 2025 · 0 likes post #75 is right about the mechanism and I think understates the practical bit. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is…
-
Coverage for the indication versus for the drug Replied, post #14 · Access › Insurance & coverage · 30 Mar 2025 · 12 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #91 · Sourcing › Vendor reports · 17 Mar 2025 · 7 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Reading order for a first week here, and what to skip until later Replied, post #38 · Start Here › Welcome · 15 Mar 2025 · 0 likes On post #34 — agreed on the reasoning, with one qualification. Welcome. The orientation materials are pinned at the top of this category and they take about an hour.…
-
Validating a method you did not develop — does this still hold? Replied, post #112 · Analytics › Method validation · 14 Mar 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #52 · Sourcing › Regulatory · 1 Mar 2025 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #17 · Analytics › Mass spectrometry · 25 Feb 2025 · 1 like Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Scheduled maintenance and what will be unavailable Replied, post #51 · Meta › Announcements · 22 Feb 2025 · 23 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #89 · Sourcing › Regulatory · 20 Feb 2025 · 32 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #14 · Access › Pricing · 20 Feb 2025 · 24 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Coming back to: Official shortage notices and what they authorise Replied, post #20 · Access › Shortages · 15 Feb 2025 · 7 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #3 · Practice › Administration · 4 Feb 2025 · 29 likes Picking up post #2: that is the part I would want checked first. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #15 · Analytics › COA interpretation · 17 Jan 2025 · 11 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Recovery when intake is low: what to cut first Replied, post #81 · Nutrition & Training › Resistance training · 14 Jan 2025 · 0 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Oxidation pathways for methionine and tryptophan Replied, post #22 · Analytics › Impurities & related substances · 27 Dec 2024 · 23 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #22 · Compounds › Repair & healing peptides · 22 Dec 2024 · 2 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #51 · Compounds › Semaglutide · 22 Dec 2024 · 17 likes Coming back to post #49, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #29 · Meta › Wiki maintenance · 7 Nov 2024 · 32 likes post #28 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
The topic list is dense — is that deliberate? Replied, post #41 · Meta › Site feedback · 21 Oct 2024 · 0 likes post #40 answers the question as asked. The question underneath it is different. Moderation decisions: if you disagree with a moderation decision, raising it here gives…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #66 · Clinical › Prescriber conversations · 28 Sep 2024 · 16 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #9 · Practice › Interactions · 18 Sep 2024 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #16 · Compounds › Oral incretins · 30 Aug 2024 · 0 likes Picking up post #13: that is the part I would want checked first. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #14 · Compounds › Oral incretins · 28 Aug 2024 · 32 likes Picking up post #11: that is the part I would want checked first. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and…
-
Correlation in a self-tracked dataset: what it can support Replied, post #7 · Research Methods › Statistics · 20 Aug 2024 · 31 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #5 · Analytics › Method validation · 2 Aug 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #44 · Practice › Dosing & titration · 10 Jul 2024 · 5 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Journal club: FLOW and the renal composite, component by component Replied, post #10 · Evidence › Journal club · 9 Jul 2024 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…